The global meningitis treatment market is estimated to be valued at USD 158.8 million in 2025 and is projected to reach USD 226.2 million by 2035, registering a CAGR of 3.6% over the forecast period.

News Release 31-Mar-2025 Experimental blood test shown to accurately indicate severity and predict potential recovery from spinal cord injury ...

Higher cfDNA concentrations were found in the ASIA A group — representing no sensation or function of motor skills — compared to less severe injuries with groups B (P = 0.04), C (P = 0.009), and D (P ...

The American Spinal Injury Association Impairment (ASIA) impairment scale is what’s used to measure spinal cord injury severity — here’s what it looks like: ...

The Delivery of Oligodendrocyte Progenitor Cells for Spinal Cord Injury: Evaluation of a Novel Device (DOSED) clinical study is an open label, multi-center, device safety study, in 3-5 subacute and ...

In the U.S., there are approximately 18,000 new spinal cord injuries annually and over 300,000 patients in total living with spinal cord injuries.

Summary: A phase 1 clinical trial has revealed that stem cells derived from patients’ own fat may safely enhance sensation and movement in individuals with traumatic spinal cord injuries. In the study ...

In the study of 10 adults—all with American Spinal Injury Association Impairment Scale (AIS) grade A or B at the time of injury—seven participants demonstrated improvements based on the ...

In the study of 10 adults, the research team noted seven participants demonstrated improvements based on the American Spinal Injury Association (ASIA) Impairment Scale.

The spinal cord has limited ability to repair its cells or make new ones. Patients typically experience most of their recovery in the first six to 12 months after injuries occur.